Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial

(MedPage Today) — HOUSTON — Survival in untreated, intermediate- and higher-risk myelodysplastic syndromes (MDS) failed to improve with the addition of the targeted agent venetoclax (Venclexta) to chemotherapy, a large randomized trial showed…

Source link : https://www.medpagetoday.com/meetingcoverage/soho/117342

Author :

Publish date : 2025-09-06 17:16:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Combo Therapy for Myelodysplastic Syndromes Misses Survival Goal in Randomized Trial

Are You Ready for Measles’ Wrath?

Who Needs a Beta-Blocker After a Heart Attack? RSV Vaccines and Hospitalizations

Related Posts

Aspirin for Colon Cancer; Private Equity Hospital Takeovers

AI’s Paradoxical Gift to Primary Care

Revised MS Criteria Aim to Speed Diagnosis

Trump’s Tylenol and Vaccine Warnings Leave Some Pregnant Women Concerned, or Angry

‘The pain was so agonizing, I walked with a stick’

If Government Shuts Down, Federal Health Programs Would Feel the Pinch

Aspirin for Colon Cancer; Private Equity Hospital Takeovers

AI’s Paradoxical Gift to Primary Care

Revised MS Criteria Aim to Speed Diagnosis

Trump’s Tylenol and Vaccine Warnings Leave Some Pregnant Women Concerned, or Angry

‘The pain was so agonizing, I walked with a stick’

If Government Shuts Down, Federal Health Programs Would Feel the Pinch

After Massive Shrimp Recalls, FDA Finds Radioactive Contamination in Spices Too

Acupuncture Eases Chronic Low Back Pain, Boosts Function

Categories

Archives